Lazard Asset Management LLC Moderna, Inc. Transaction History

Lazard Asset Management LLC

$68.3 Billion
Q3 2024

A detailed history of Lazard Asset Management LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 14,185 shares of MRNA stock, worth $476,757. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,185

Previous 51,122 72.25%

Holding current value

$476,757

Previous $6.07 Million 84.4%

% of portfolio

0.0%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$63.64 - $125.14 $2.35 Million - $4.62 Million	-36,937 Reduced 72.25%	14,185 $947,000
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $4.14 Million - $6.82 Million	40,951 Added 402.63%	51,122 $6.07 Million
Q1 2024 May 14, 2024	BUY	$85.37 - $115.44 $389,543 - $526,752	4,563 Added 81.37%	10,171 $1.08 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $167,449 - $251,571	-2,409 Reduced 30.05%	5,608 $557,000
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $103,929 - $136,485	1,078 Added 15.54%	8,017 $828,000
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $1.14 Million - $1.55 Million	-9,654 Reduced 58.18%	6,939 $843,000
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $69,186 - $100,480	510 Added 3.17%	16,593 $2.55 Million
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $5.19 Million - $9.2 Million	-43,824 Reduced 73.15%	16,083 $2.89 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $2.34 Million - $3.84 Million	19,799 Added 49.36%	59,907 $7.08 Million
Q2 2022 Aug 09, 2022	BUY	$117.13 - $176.59 $2.73 Million - $4.11 Million	23,274 Added 138.26%	40,108 $5.73 Million
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $3.75 Million - $6.97 Million	-29,655 Reduced 63.79%	16,834 $2.9 Million
Q4 2021 Feb 09, 2022	SELL	$225.82 - $368.51 $9.82 Million - $16 Million	-43,500 Reduced 48.34%	46,489 $11.8 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $112,281 - $245,141	506 Added 0.57%	89,989 $34.6 Million
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $9.08 Million - $16.4 Million	69,859 Added 355.99%	89,483 $21 Million
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $1.86 Million - $3.16 Million	16,995 Added 646.44%	19,624 $2.57 Million
Q4 2020 Feb 11, 2021	BUY	$65.74 - $169.86 $172,830 - $446,561	2,629 New	2,629 $274,000

Others Institutions Holding MRNA

# of Institutions

911

Shares Held

235M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $13.1B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Moderna, Inc. Transaction History